Albemarle (ALB) Valuation Check After Recent Share Price Swings
Albemarle Corporation ALB | 0.00 |
Albemarle (ALB) is back on many investors’ screens after recent share price moves, with the stock up about 2% over the past year but down roughly 11% over the past month.
At a share price of $171.77, Albemarle’s recent 30 day share price return of down 11.4% contrasts with a year to date share price return of 19.34%. The 1 year total shareholder return of about 206.59% sits against a 3 year total shareholder return that declined 15.67% and a 5 year total shareholder return of 3.53%. This suggests that strong recent momentum has come after a much weaker longer run.
If Albemarle’s swings have you thinking about where else capital could work, this is a good moment to size up other lithium and materials plays through our 32 best rare earth metal stocks
After such a sharp swing in returns and a share price at $171.77, the key question is whether Albemarle’s current valuation and discounts to some intrinsic estimates hint at mispricing, or if the market is already accounting for future growth.
Most Popular Narrative: 19.3% Undervalued
With Albemarle last closing at $171.77 against a narrative fair value of $212.74, the widely followed view sees meaningful upside potential built into its future cash generation.
The company is executing aggressive cost reduction and productivity initiatives (achieving a $400M annual run-rate in savings, 6 months ahead of plan), ramping low-cost asset expansions, and optimizing its conversion network, which is likely to structurally reduce operating costs and increase net margins in a lower price environment.
Want to see what kind of revenue trajectory and margin rebuild sits behind that efficiency push and fair value gap? The key is how future earnings, margins and valuation multiple are aligned across the next few years.
Result: Fair Value of $212.74 (UNDERVALUED)
However, this hinges on lithium prices and industry capacity, with prolonged low pricing or persistent oversupply both capable of quickly challenging the current efficiency-driven narrative.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
Another Angle On Valuation: Sales Multiple Looks Stretchy
While our DCF work suggests Albemarle is trading about 48.9% below an estimated future cash flow value of $335.98, the P/S ratio paints a very different picture. At 3.7x sales versus a fair ratio of 2x and a US Chemicals industry average of 1.1x, the stock screens as expensive on revenue today, raising the question of how much future improvement is already priced in.
Investors weighing these two signals may want to stress test their own assumptions about lithium pricing, margins and growth before leaning too heavily on either model, then decide which framework lines up best with their risk tolerance and time horizon. See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Big valuation swings and mixed sentiment can be hard to read, so move quickly, check the underlying numbers yourself and weigh the 2 key rewards and 1 important warning sign
Looking for more investment ideas?
If Albemarle has you thinking more broadly about where to put fresh capital next, do not stop here. Widen your search and pressure test new ideas.
- Target companies that combine strong cash generation with attractive entry prices by scanning our 46 high quality undervalued stocks.
- Prioritize reliable income streams by reviewing stocks in the 11 dividend fortresses.
- Focus on financial resilience and balance sheet strength by checking the solid balance sheet and fundamentals stocks screener (47 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
